News | June 03, 2024
PharmaLytica 2024: India exported US$ 27.8 billion worth of drugs in FY 2023-24
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
2024 full-year revenue guidance raised by US$ 2 billion
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Connecting new production and consumption areas of chilled food by low-carbon transportation services
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
Subscribe To Our Newsletter & Stay Updated
